- Home
- BNTX vs BEKE Comparison
BNTX vs BEKE Comparison
Compare BNTX & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNTX | BEKE |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | Germany | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 18.8B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BNTX | BEKE |
|---|---|---|
| Price | $91.58 | $16.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $137.40 | $24.36 |
| AVG Volume (30 Days) | 1.4M | ★ 4.6M |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $3,698,814,972.00 | ★ $14,540,474,652.00 |
| Revenue This Year | $2.36 | $7.14 |
| Revenue Next Year | N/A | $4.90 |
| P/E Ratio | ★ N/A | $39.47 |
| Revenue Growth | 3.70 | ★ 25.42 |
| 52 Week Low | $81.20 | $15.39 |
| 52 Week High | $129.27 | $25.17 |
Technical Indicators
Market Signals| Indicator | BNTX | BEKE |
|---|---|---|
| Relative Strength Index (RSI) | 32.13 | 41.58 |
| Support Level | $94.52 | $16.14 |
| Resistance Level | $97.35 | $17.66 |
| Average True Range (ATR) | 2.33 | 0.32 |
| MACD | -0.42 | -0.03 |
| Stochastic Oscillator | 2.64 | 11.80 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About BEKE KE Holdings Inc (each representing three)
KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.